These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 35820417)
61. [Bacteriophages in the battle against multidrug resistant bacteria]. van der Meer JWM; Vandenbroucke-Grauls CMJE Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928 [TBL] [Abstract][Full Text] [Related]
62. Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli. Rahmani R; Zarrini G; Sheikhzadeh F; Aghamohammadzadeh N Jundishapur J Microbiol; 2015 Feb; 8(2):e17744. PubMed ID: 25834712 [TBL] [Abstract][Full Text] [Related]
63. Mutant and Recombinant Phages Selected from Peters TL; Song Y; Bryan DW; Hudson LK; Denes TG Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887717 [TBL] [Abstract][Full Text] [Related]
64. Novel "Superspreader" Bacteriophages Promote Horizontal Gene Transfer by Transformation. Keen EC; Bliskovsky VV; Malagon F; Baker JD; Prince JS; Klaus JS; Adhya SL mBio; 2017 Jan; 8(1):. PubMed ID: 28096488 [TBL] [Abstract][Full Text] [Related]
65. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
66. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii. Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836 [TBL] [Abstract][Full Text] [Related]
70. Šimoliūnienė M; Kazlauskas D; Zajančkauskaitė A; Meškys R; Truncaitė L Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129967. PubMed ID: 34324954 [TBL] [Abstract][Full Text] [Related]
71. Phages and their potential to modulate the microbiome and immunity. Federici S; Nobs SP; Elinav E Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128 [TBL] [Abstract][Full Text] [Related]
72. Characterization and genome analysis of novel Klebsiella phage BUCT556A with lytic activity against carbapenemase-producing Klebsiella pneumoniae. Feng J; Gao L; Li L; Zhang Z; Wu C; Li F; Tong Y Virus Res; 2021 Oct; 303():198506. PubMed ID: 34271040 [TBL] [Abstract][Full Text] [Related]
73. Challenges and opportunities of phage therapy for Kou X; Yang X; Zheng R Appl Environ Microbiol; 2024 Oct; 90(10):e0135324. PubMed ID: 39345202 [TBL] [Abstract][Full Text] [Related]
74. Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections. Regeimbal JM; Jacobs AC; Corey BW; Henry MS; Thompson MG; Pavlicek RL; Quinones J; Hannah RM; Ghebremedhin M; Crane NJ; Zurawski DV; Teneza-Mora NC; Biswas B; Hall ER Antimicrob Agents Chemother; 2016 Oct; 60(10):5806-16. PubMed ID: 27431214 [TBL] [Abstract][Full Text] [Related]
75. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future. Łobocka M; Dąbrowska K; Górski A BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767 [TBL] [Abstract][Full Text] [Related]
76. Engineering of receptor-binding proteins in bacteriophages and phage tail-like bacteriocins. Dams D; Brøndsted L; Drulis-Kawa Z; Briers Y Biochem Soc Trans; 2019 Feb; 47(1):449-460. PubMed ID: 30783013 [TBL] [Abstract][Full Text] [Related]
77. Laird T; Abraham R; Sahibzada S; Abraham S; O'Dea M Appl Environ Microbiol; 2022 Apr; 88(7):e0227621. PubMed ID: 35254097 [TBL] [Abstract][Full Text] [Related]
78. Isolation and Characterization of a Novel Phage for Controlling Multidrug-Resistant Peng Q; Fang M; Liu X; Zhang C; Liu Y; Yuan Y Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32283667 [TBL] [Abstract][Full Text] [Related]
79. Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen Deng S; Xu Q; Fu Y; Liang L; Wu Y; Peng F; Gao M Viruses; 2021 May; 13(6):. PubMed ID: 34072620 [TBL] [Abstract][Full Text] [Related]